The prospective, single-arm clinical study will involve up to 15 sites across the U.S. and include 130 patients.
The study will examine the possibility of removing the self-expanding stent after the treatment of malignant and benign strictures. The study will also serve as an evaluation of the device’s use in esophageal conditions, including leaks, perforations, fistulas and strictures.
More Articles on Gastroenterology:
The Changing Healthcare Environment & Gastroenterologists: Q&A With Dr. Edwin Levine
Norwalk Hospital Adds Dr. Summa S. Magge
FDA Advisory Committee Reviews Vedolizumab Safety Concerns
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
